Brief summary of the agreement
Anyone is free:
· to copy, distribute, and display the work;
· to make derivative works;
· to make commercial use of the work;
Under the following conditions: Attribution
· the original author must be given credit;
· for any reuse or distribution, it must be made clear to others what the license terms of this work are;
· any of these conditions can be waived if the authors gives permission.
Statutory fair use and other rights are in no way affected by the above
Author Biographies
Amel Achour Jenayah
Department "A" of Gynecology and Obstetrics, Center of Maternity and Neonatology of Tunis, Tunisia
Hajer Bettaieb
Department "A" of Gynecology and Obstetrics, Center of Maternity and Neonatology of Tunis, Tunisia
Sarra Saoudi
Department "A" of Gynecology and Obstetrics, Center of Maternity and Neonatology of Tunis, Tunisia
Anissa Gharsa
Department "A" of Gynecology and Obstetrics, Center of Maternity and Neonatology of Tunis, Tunisia
Ezzeddine Sfar
Department "A" of Gynecology and Obstetrics, Center of Maternity and Neonatology of Tunis, Tunisia
Fethia Boudaya
Department "A" of Gynecology and Obstetrics, Center of Maternity and Neonatology of Tunis, Tunisia
Dalenda Chelli
Department "A" of Gynecology and Obstetrics, Center of Maternity and Neonatology of Tunis, Tunisia
Main Article Content
Desmoid tumors: clinical features and treatment options: a case report and a review of literature
Amel Achour Jenayah
Hajer Bettaieb
Sarra Saoudi
Anissa Gharsa
Ezzeddine Sfar
Fethia Boudaya
Dalenda Chelli
Abstract
Desmoid tumors are a rare group of locally aggressive, non malignant tumors of fibroblastic origin that can lead to significant morbidity due to local invasion and may even result in a fatal outcome when located around vital organs. Their clinical presentation, biological behavior and natural history can be quite varied and is incompletely understood at the present time. The optimal therapeutic approach depends on various factors, and a multidisciplinary approach is necessary to achieve local control with acceptable morbidity. Despite progress in the understanding of these tumors and the treatment options, local recurrence remains a major problem.
Pan African Medical Journal 2015; 21
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.